Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AVI 7288

Drug Profile

AVI 7288

Alternative Names: AVI-7288

Latest Information Update: 16 Jul 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AVI BioPharma
  • Developer Sarepta Therapeutics; United States Department of Defense
  • Class Antisense oligonucleotides; Antivirals
  • Mechanism of Action RNA interference; Viral RNA inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Marburg virus disease
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Marburg virus disease

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Marburg virus disease(In volunteers) in USA (IV, Infusion)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Marburg virus disease in USA (IM)
  • 10 Feb 2014 Adverse events data from a phase I, multiple ascending dose (MAD) trial in Marburg virus disease (in volunteers) released by Sarepta Therapeutics

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top